More than 2 million middle and high school students said they used e-cigarettes last year, the American Lung Association found in its 20th annual State of Tobacco Control report.
The Latest
Yale Cancer Center has appointed Mark Lemmon, PhD, as its deputy director, the facility said Jan. 25.
Boston-based Dana-Farber Cancer Institute named Scarborough, Maine-based New England Cancer Specialists its first affiliate member in Maine, the institute said Jan. 25.
Increasing diversity and accessibility to clinical trials is key to closing racial gaps in cancer care, Kathy Giusti and John Carpten, MD, wrote for The Hill Jan. 24.
Here are four cancer-related partnerships formed since Jan. 14.
The University of Chicago Medicine Comprehensive Cancer Center appointed Mary Dolan, PhD, its deputy director, the center said Jan. 19.
The University of Texas MD Anderson Cancer Center in Houston and Planegg, Germany-based Eisbach Bio GmbH announced a research collaboration on Jan. 19 dedicated to discovering and developing precision oncology drugs that target synthetic lethal engines.
Recent cancer research has focused on nationwide death rates from the disease since 2019, lung-cancer assessment risks using blood samples and more.
Edison, N.J.-based Hackensack Meridian Health and Paterson, N.J.-based St. Joseph's Health announced a clinical affiliation Jan. 14 to bring patients expanded oncologic services.
Overall cancer deaths in the U.S. have declined 32 percent since 2019, according to a report published Jan. 12 in CA: A Cancer Journal for Clinicians.